Objectives: The aim of this study was to determine the incidence of toxic trough serum gentamicin levels in neonates in the first week of life, with different dosage intervals. Methods: This was a retrospective study of neonates born between 01.07.95 and 31.12.95, who received gentamicin. Data were collected on birth weight, gestation, gentamicin dose, the trough level of gentamicin, serum creatinine and urine output. A trough serum gentamicin level of ≥1.5 mg/L was considered toxic. Results: One hundred and seventy infants met the study criteria. All 21 infants in group one (24-29 weeks) received gentamicin with a dosage interval of 24 h. Sixteen (76%) infants had toxic trough serum gentamicin levels. In group two (30-34 weeks) 8 infants had gentamicin q12hly and all (100%) had toxic trough serum gentamicin levels. Fourteen infants had gentamicin every 18 h and 13 (93%) had toxic trough serum gentamicin levels. Sixty-one infants had gentamicin q24hly and 25 (41%) had toxic trough serum gentamicin levels. The differences in proportions with toxic levels were statistically significant. In group three (≥35 weeks) 29 infants had gentamicin q12hly and 25 (86%) had toxic trough serum gentamicin levels. Six infants had gentamicin every 18 h and 2 (33%) had toxic trough serum gentamicin levels. Thirty-one infants had gentamicin q24hly and 4 (13%) had toxic trough serum gentamicin levels. The differences in proportions comparing infants having gentamicin q12hly with those having it q24hly were statistically significant. Conclusions: A starting gentamicin dosage interval of 12 h in infants of any gestational age, or a starting dosage interval of 24 h for infants of less than 30 weeks gestational age, leads to most having toxic trough serum gentamicin levels. In infants of 30 weeks gestational age or greater, most have safe non-toxic trough serum gentamicin levels if started on a dosage interval of 24 h.
Gentamicin is one of the most common antibiotics used in first week of life and to determine if the incidence differed with dosage interval. neonatal units. It is used in the first line treatment for sepsis in the neonate. Serum gentamicin levels are monitored routinely, particularly to check predose trough levels to avoid toxic accumulation.
METHODS
The starting dose and dosage interval of gentamicin are usually based on the infant's weight and gestation.1-3 Over the This was a retrospective study of all infants born between last decade, there has been a shift from giving the drug every 01.07.95 and 31.12.95 admitted to our neonatal unit who 12 h, in the term infant, to giving a larger dose every 24 h received gentamicin intravenously. Data were collected (per-(q24hly).1,4,5 This has resulted from studies done in adults and taining to the first course of gentamicin commenced in the first children.6-10 Conflicting advice on gentamicin dosing regimens week of life) on the infant's birth weight, gestation, dose and from commonly used paediatric and neonatal drug dosage dosage interval of gentamicin, the trough level of gentamicin booklets in Australia over the last few years1,4,5 has led to the before the third dose, serum creatinine on the day of the situation where neonatal house staff have been commencing gentamicin level and the urine output in the 24 h prior to the neonates on varying doses and dosage intervals of gentamicin. gentamicin level. It was our impression that infants who received gentamicin Infants were excluded from the analysis if: (1) no gentamicin every 12 h (q12hly) had higher trough levels, requiring lengthenlevel was carried out; (2) the dosage interval was not clearly ing of the dosage interval, than infants who received the known; (3) the dose or dosage interval of gentamicin were drug q24hly. altered before the serum gentamicin level was carried out; and The aim of this study is to determine the incidence of (4) renal function was impaired-defined as having a serum inappropriately high trough gentamicin levels in neonates in the creatinine greater than 0.09 mmol/L or a poor urine output (less than 1 mL/kg/h if measured, or less than four wet nappies in the 24 h preceding the gentamicin level). Infants were also interval of gentamicin was increased.
RESULTS
the dosage interval of gentamicin the greater the likelihood of high trough levels. Non-toxic or safe trough gentamicin levels are set arbitrarily One hundred and seventy infants met the study criteria. The infants were divided into three groups for analysis. Group one, and there is no good evidence that any particular trough level to aim for is correct-threshold levels between 0.5 and 2.0 mg/L infants from 24 to 29 completed weeks gestation (n=21). Group two, infants from 30 to 34 completed weeks gestation (n=83).
have been recommended.11 The threshold level we use for trough gentamicin levels is 1.5 mg/L. Our gentamicin assays Group three, infants of ≥35 weeks gestation (n=66). Birthweights, gestational ages and gentamicin doses are are carried out at the Department of Microbiology, Royal Brisbane Hospital. They recommend that gentamicin dosage summarised in Table 1 .
All 21 infants in group one received gentamicin q24hly. intervals be increased if levels are ≥1.5 mg/L. This level was initially introduced years ago before the use of TDX technology Sixteen (76%) infants had toxic trough serum gentamicin levels.
In group two, 8 infants had gentamicin q12hly and all (100%) with its speed of turnaround time of 1-2 h. The recommended level has been retained ''because it has an inbuilt sense of had toxic trough serum gentamicin levels. These infants were significantly larger and more mature than the infants receiving 'safety' in case of delays in action by clinical staff or if there is a loss of test sensitivity/reproducibility, and because staff are gentamicin q24hly. Fourteen infants had gentamicin every 18 h (q18hly) and 13 (93%) had toxic trough serum gentamicin levels.
familiar with and understand what it means''. (Faoagali J, personal communication, 1997). These infants were significantly larger than the infants receiving gentamicin q24hly. Sixty-one infants had gentamicin q24hly and Toxicity of aminoglycosides is related to accumulation of the drug if it is given too often. Harmful effects on the kidney and 25 (41%) had toxic trough serum gentamicin levels. The differences in proportions with toxic levels were statistically middle ear can lead to renal failure and deafness.12,13 Renal toxicity results from accumulation of gentamicin in lysosomes significant (Table 2) . That is gentamicin given every 12 or 18 h was more likely to lead to toxic trough serum gentamicin levels of cells in the proximal tubule. This leads to disordered reabsorption and decreased glomerular filtration rate.14 Auditory compared with gentamicin given q24hly.
In group three, 29 infants had gentamicin q12hly and 25 brain stem evoked responses in neonates demonstrate a clear effect from gentamicin (even in the absence of any trough (86%) had toxic trough serum gentamicin levels. These infants were significantly larger than the infants receiving gentamicin gentamicin levels of ≥2.0 mg/L) and animal studies demonstrate anatomical damage to the cochlea with electron microscopy.15 q24hly. Six infants had gentamicin q18hly and 2 (33%) had toxic trough serum gentamicin levels. Thirty-one infants had However, sensorineural hearing loss is common in graduates of neonatal intensive care16 and the contribution of gentamicin is gentamicin q24hly and 4 (13%) had toxic trough serum gentamicin levels. The differences in proportions comparing largely unknown.16,17
Once the decision has been made to start a baby on infants having gentamicin q12hly with those having it q24hly were statistically significant (Table 2) . That is gentamicin given gentamicin the clinician must then decide how much of the drug to give (the dose) and how often to give it (the dosage q12hly was more likely to lead to toxic trough serum gentamicin levels than was gentamicin given q24hly. interval). For term neonates, the recommended dosage regimen up until the early 1990s has been 2.5 mg/kg/dose given q12hly.1,4 Neonates have a longer half life for gentamicin than adults18 and in the very preterm infant it may be prolonged to DISCUSSION 14 h.19 Therefore neonates require a longer dosage interval compared with older children and adults, and preterm neonates In our unit, in 1995, infants were commenced on different dosing regimens of gentamicin. This gave us an opportunity to require even longer dosage intervals. Preterm neonates also have a larger volume of distribution for gentamicin than more ascertain how many of our infants had toxic trough serum gentamicin levels and to see if the incidence of toxicity varied mature infants and may require larger doses of gentamicin to achieve adequate peak gentamicin levels.20-23 with the dosage interval. Any evidence of renal impairment would normally influence the prescribed dosage interval and There are many compelling reasons for giving gentamicin less often, apart from the decreased incidence of high trough gentamicin clearance, so we excluded these infants from our analysis. Our results confirm our impression that the shorter levels found in this study. These include savings related to drug costs and nursing time, the postantibiotic effect and decreased CONCLUSION postexposure resistance. The postantibiotic effect is that time after administration of an antibiotic when bacterial regrowth A starting gentamicin dosage interval of 12 h in infants of any gestational age leads to most having toxic trough serum does not occur despite the concentration of antibiotic being below the minimum inhibitory concentration.6,7,9,10,13,24 It is gentamicin levels. The same can be said for infants of less than 30 weeks gestational age with a starting dosage interval of probably due to disrupted and/or delayed bacterial protein synthesis. The length of the postantibiotic effect is variable and 24 h. In infants of 30 weeks gestational age or greater, most have safe non-toxic trough serum gentamicin levels if started the factors that determine it are unknown. Post-exposure resistance is a phenomenon in which organisms are more likely on a dosage interval of 24 h. In our unit, as a result of the above data, we recommend to develop resistance to an antibiotic if they are continuously exposed to it. 24 The effect has been demonstrated in vitro for that gentamicin is commenced at a dose of 2.5 mg/kg at a dosage interval of 36 h for infants less than 30 weeks gestation many antibiotics including aminoglycosides. It can lead to a progressive decrease in antibiotic efficacy and may result in and a dosage interval of 24 h for infants of 30 weeks or more. resistant organisms. Once daily dosing minimises contact time with the organism decreasing the incidence of postexposure REFERENCES resistance.
In the light of our results, we cannot continue to use a efficacy of gentamicin.
